Skip to Content

Pulsion Medical Systems SE 0NFX

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

0NFX is trading at a 87% premium.
Price
€21.09
Fair Value
€29.39
Uncertainty
Very High
1-Star Price
€85.52
5-Star Price
€69.15
Economic Moat
Lktl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 0NFX is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
€0.00 / €0.00
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
66

Comparables

Valuation

Metric
0NFX
CHG
M7U
Price/Earnings (Normalized)
1,991.0630.28
Price/Book Value
4.112.14
Price/Sales
6.561.61
Price/Cash Flow
34.3217.87
Price/Earnings
0NFX
CHG
M7U

Financial Strength

Metric
0NFX
CHG
M7U
Quick Ratio
1.202.541.36
Current Ratio
1.933.002.47
Interest Coverage
5,475.87−2.3514.38
Quick Ratio
0NFX
CHG
M7U

Profitability

Metric
0NFX
CHG
M7U
Return on Assets (Normalized)
22.01%0.11%5.83%
Return on Equity (Normalized)
31.17%0.21%10.40%
Return on Invested Capital (Normalized)
31.06%1.14%7.67%
Return on Assets
0NFX
CHG
M7U
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesHlmysghYvpkln$182.3 Bil
SYK
Stryker CorpZvfsqqfvyxXtkhr$123.5 Bil
MDT
Medtronic PLCSwbpzgvHztbrh$111.9 Bil
BSX
Boston Scientific CorpHfpdpbkxCqnyvp$108.0 Bil
EW
Edwards Lifesciences CorpXxkfzpvghpRmhnvpw$52.1 Bil
DXCM
DexCom IncJdwdwzbdTnkgb$49.5 Bil
ZBH
Zimmer Biomet Holdings IncGjjqrwllgGfncc$24.7 Bil
PHG
Koninklijke Philips NV ADRSkdjvsklDwbjzg$24.5 Bil
ALGN
Align Technology IncDpyrhmqzKnsvf$20.5 Bil
PODD
Insulet CorpNytnxcwnyWqmwgw$11.3 Bil

Sponsor Center